Coherus BioSciences (CHRS) Reports Q4 Loss of $1.72/Share
Tweet
Share
E-mailGet Alerts CHRS Hot Sheet
Price: $1.34 +16.52%
Financial Fact:
Basic net income/(loss) per share: 0.15
Today's EPS Names:
PODC, CLIR, ARDS, More
Financial Fact:
Basic net income/(loss) per share: 0.15
Today's EPS Names:
PODC, CLIR, ARDS, More
Join SI Premium – FREE
Coherus BioSciences (NASDAQ: CHRS) reported Q4 EPS of ($1.72), versus ($1.56) reported last year. Revenue for the quarter came in at $14.07 million, versus $6.87 million reported last year.
For earnings history and earnings-related data on Coherus BioSciences (CHRS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
- Keysight Technologies (KEYS) Tops Q3 EPS by 59c; Offers Guidance
- CLSA Starts Beike (BEKE) at Outperform (2)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
